Trial Profile
Clinical Trials Insight: 700016893
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2006
Price :
$35
*
At a glance
- Drugs VIR 201 (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Prescient Therapeutics
- 25 Oct 2006 New trial record.